A reminder that the Malecare teleconference on advanced prostate cancer is today Conference Time: 6:00 PM ET, 5:00 PM CT, 4:00 PM MT, 3:00PM PT Participant Dialing Instructions: Toll Free Number: 1.800.868.1837 Direct Dial/Int’l Number: 1.404.920.6440 Conference Code: 786432# […]
Recent statistics projecting the cancer incidence in the United States for 2010 have a number of interesting items buried inside the data charts. I thought that three items were particularly interesting and relevant, so I want to share them with you. 1- The 2010 expected death rate per 100,000 cases for the "Good Cancer" (prostate [...]
One of the more common experiences many of us have when fighting advanced prostate cancer is fatigue. Despite how common fatigue is in men with advanced disease there has not been even one published controlled trial of interventions for fatigue! A research team at the Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, [...]
In men with prostate cancer hot flashes are one of the most commonly reported adverse effects of hormonal therapy (ADT). Researchers at the Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon wanted to confirm the many reports that acupuncture can moderate hot flashes. […]
When you are diagnosed with cancer one of the hurdles you might face is a financial one. Bills can accumulate quickly so it might be a good idea to seek financial help early on after being diagnosed. […]
One of the largest and most controversial issues for the treatment of advanced prostate cancer is the value of androgen-deprivation therapy (ADT). Most doctors use ADT as their pivotal initial treatment in the management of locally advanced and metastatic prostate cancer (PCa). But, the grand question is does it extend survival? […]
The prognosis of patients with advanced prostate cancer who have lymph node metastasis depends on the number of positive lymph nodes removed and Gleason score of the primary tumor. Bilateral pelvic lymph node dissection should be performed in intermediate- and high-risk patients to identify those with minimal nodal burden who may benefit the most from [...]
Join us for a conversation about treating advanced stage prostate cancer, with James M. McKiernan, M.D. and Joel Nowak, M.A., M.S.W. […]
What is the real cost of approved treatments for advanced prostate cancer and how much we should spend? These questions are rippling through the prostate cancer community and the general population. […]
Genetic counseling is common place in the world of breast cancer including the evaluation of the BRCA genes. Prostate and breast cancer increasingly been shown to have a relationship, perhaps all the down to the genetic level. Researchers are now understanding, that like in breast cancer, BRCA1 loss preexisting in small sub-populations of prostate cancer [...]
